Hybrid positron emission tomography (PET)/magnetic resonance imaging (MRI) is highly suited for abdominal pathologies. A precise co-registration of anatomic and metabolic data is possible thanks to the simultaneous acquisition, leading to accurate imaging. The literature shows that PET/MRI is at least as good as PET/CT and even superior for some indications, such as primary hepatic tumors, distant metastasis evaluation, and inflammatory bowel disease. PET/MRI allows whole-body staging in a single session, improving health care efficiency and patient comfort.
Keywords: Fluorodeoxyglucose F18; Ionizing; Liver neoplasms; Lymphadenopathy; Magnetic resonance imaging; Perfusion imaging; Positron-emission tomography; Radiation.
Copyright © 2023 Elsevier Inc. All rights reserved.